C&S Partners, Stratage Law Act On Dr. Lal PathLabs’ Acquisition Of 70% Stake In SN Genelab

November 13, 2026

C&S Partners and Stratage Law Partners advised on Dr. Lal PathLabs’ acquisition of 70% stake in SN Genelab.

Dr. Lal PathLabs Limited has acquired a 70% stake in SN Genelab Private Limited, a Gujarat-based company providing diagnostics and genomics services.

C&S Partners advised Dr. Lal PathLabs on the acquisition.

The transaction team consisted of Partner Saurabh Tiwari, Associate Arya Sharma and Associate Aditya Singh.

Senior Partner Deepali Chandhoke provided strategic inputs on employment law issues.

Stratage Law Partners advised SN Genelab Private Limited and its selling shareholders/promoters in connection with the acquisition.

The team comprised Managing Partner Darshan Upadhyay, Senior Partner Shyam Pandya, Senior Associate Abhay Gaur, Senior Associate Ishan Saxena, Associate Atul More and Associate Adarsh Kashyap.

Abhay Gaur, Adarsh Kashyap, Aditya Singh, Arya Sharma, Atul More, Darshan Upadhyay, Deepali Chandhoke, Ishan Saxena, Saurabh Tiwari, Shyam Pandya

Healthcare & Diagnostics

Mergers & Acquisitions

The deal reporting on this platform is based on the information received from law firms, and therefore, some details may be missing/incomplete. If your firm has not been credited for this deal, write to us at connect@thedealmatter.com mentioning your firm’s name, lawyers involved (including designation) and client represented.